As a follow up to survey results released on March 11, 2020, April 14, 2020 and July 20, 2020, today Institute for Supply Management® (ISM®) released its fourth round of dedicated research on COVID-19 impacts on businesses and their supply chains.
Analysis of a poll conducted by Verdict to assess the impact of COVID-19 on the drug supply chain showed that 90% are either highly or partially concerned about the disruption.